| CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
3.68% |
|
|
|
|
|
N/A |
0.00% |
51.57% |
36.40% |
|---|
| ALKS |
Alkermes plc |
0 |
3.65% |
|
|
|
|
|
N/A |
0.00% |
61.11% |
49.40% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
0 |
3.22% |
|
|
|
|
|
N/A |
0.00% |
39.47% |
10.29% |
|---|
| VRNA |
Verona Pharma plc |
0 |
3.01% |
|
|
|
|
|
N/A |
0.00% |
20.52% |
11.20% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
0 |
2.77% |
|
|
|
|
|
N/A |
0.00% |
43.89% |
11.18% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
2.73% |
|
|
|
|
|
N/A |
0.00% |
95.01% |
66.43% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
0 |
2.71% |
|
|
|
|
|
N/A |
0.00% |
46.04% |
18.47% |
|---|
| MLTX |
MoonLake Immunotherapeutics |
0 |
2.62% |
|
|
|
|
|
N/A |
0.00% |
210.68% |
106.18% |
|---|
| XENE |
Xenon Pharmaceuticals Inc. |
0 |
2.30% |
|
|
|
|
|
N/A |
0.00% |
47.67% |
11.77% |
|---|
| DNLI |
Denali Therapeutics Inc. |
0 |
2.28% |
|
|
|
|
|
N/A |
0.00% |
755.03% |
28.62% |
|---|
| ZLAB |
Zai Lab Limited |
0 |
2.27% |
|
|
|
|
|
N/A |
0.00% |
74.73% |
43.14% |
|---|
| MRUS |
Merus N.V. |
0 |
2.25% |
|
|
|
|
|
N/A |
0.00% |
54.56% |
16.21% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
0 |
2.20% |
|
|
|
|
|
N/A |
0.00% |
373.92% |
81.66% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
2.18% |
|
|
|
|
|
N/A |
0.00% |
36.46% |
24.34% |
|---|
| VCEL |
Vericel Corporation |
0 |
2.14% |
|
|
|
|
|
N/A |
0.00% |
67.96% |
62.07% |
|---|
| VERA |
Vera Therapeutics, Inc. |
0 |
2.09% |
|
|
|
|
|
N/A |
0.00% |
1,349.48% |
12.67% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
0 |
2.01% |
|
|
|
|
|
N/A |
0.00% |
71.91% |
13.97% |
|---|
| NAMS |
NewAmsterdam Pharma Company N.V. |
0 |
1.85% |
|
|
|
|
|
N/A |
0.00% |
114.60% |
19.39% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
1.80% |
|
|
|
|
|
N/A |
0.00% |
43.17% |
15.10% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
0 |
1.69% |
|
|
|
|
|
N/A |
0.00% |
73.66% |
38.10% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
0 |
1.64% |
|
|
|
|
|
N/A |
0.00% |
44.07% |
14.00% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
0 |
1.58% |
|
|
|
|
|
N/A |
0.00% |
73.96% |
7.36% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
1.55% |
|
|
|
|
|
N/A |
0.00% |
38.05% |
12.43% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
0 |
1.53% |
|
|
|
|
|
N/A |
0.00% |
48.53% |
9.56% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
0 |
1.51% |
|
|
|
|
|
N/A |
0.00% |
215.85% |
21.74% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
0 |
1.48% |
|
|
|
|
|
N/A |
0.00% |
67.64% |
49.88% |
|---|
| IRON |
Disc Medicine, Inc. |
0 |
1.44% |
|
|
|
|
|
N/A |
0.00% |
42.88% |
7.41% |
|---|
| GLPG |
Galapagos NV |
0 |
1.41% |
|
|
|
|
|
N/A |
0.00% |
333.83% |
43.86% |
|---|
| MNKD |
MannKind Corporation |
0 |
1.41% |
|
|
|
|
|
N/A |
0.00% |
151.61% |
42.93% |
|---|
| NMRA |
Neumora Therapeutics, Inc. Common Stock |
0 |
1.40% |
|
|
|
|
|
N/A |
0.00% |
334.65% |
23.03% |
|---|
| CLDX |
Celldex Therapeutics, Inc. |
0 |
1.31% |
|
|
|
|
|
N/A |
0.00% |
217.01% |
13.79% |
|---|
| XNCR |
Xencor, Inc. |
0 |
1.30% |
|
|
|
|
|
N/A |
0.00% |
864.64% |
40.49% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
1.22% |
|
|
|
|
|
N/A |
0.00% |
811.48% |
27.42% |
|---|
| VRDN |
Viridian Therapeutics, Inc. |
0 |
1.21% |
|
|
|
|
|
N/A |
0.00% |
558.54% |
37.38% |
|---|
| GPCR |
Structure Therapeutics Inc. |
0 |
1.19% |
|
|
|
|
|
N/A |
0.00% |
71.86% |
53.72% |
|---|
| IMCR |
Immunocore Holdings plc |
0 |
1.14% |
|
|
|
|
|
N/A |
0.00% |
175.07% |
21.74% |
|---|
| PRAX |
Praxis Precision Medicines, Inc. |
0 |
1.11% |
|
|
|
|
|
N/A |
0.00% |
84.92% |
26.03% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
0 |
1.07% |
|
|
|
|
|
N/A |
0.00% |
292.80% |
64.68% |
|---|
| AUPH |
Aurinia Pharmaceuticals Inc. |
0 |
1.03% |
|
|
|
|
|
N/A |
0.00% |
41.05% |
35.17% |
|---|
| NVAX |
Novavax, Inc. |
0 |
1.00% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
|---|
| DAWN |
Day One Biopharmaceuticals, Inc. |
0 |
0.99% |
|
|
|
|
|
N/A |
0.00% |
393.11% |
71.16% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
0.91% |
|
|
|
|
|
N/A |
0.00% |
90.64% |
38.85% |
|---|
| PHVS |
Pharvaris N.V. |
0 |
0.81% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
|---|
| VIR |
Vir Biotechnology, Inc. |
0 |
0.79% |
|
|
|
|
|
N/A |
0.00% |
114.30% |
29.65% |
|---|
| LQDA |
Liquidia Corporation |
0 |
0.76% |
|
|
|
|
|
N/A |
0.00% |
102.28% |
49.79% |
|---|
| AVXL |
Anavex Life Sciences Corp. |
0 |
0.73% |
|
|
|
|
|
N/A |
0.00% |
111.21% |
62.79% |
|---|
| REPL |
Replimune Group, Inc. |
0 |
0.73% |
|
|
|
|
|
N/A |
0.00% |
101.28% |
36.97% |
|---|
| UPB |
Upstream Bio Inc. |
|
0.72% |
|
|
|
|
|
|
|
|
|
|---|
| AVBP |
ArriVent BioPharma, Inc. Common Stock |
0 |
0.71% |
|
|
|
|
|
N/A |
0.00% |
140.47% |
57.84% |
|---|
| NUVB |
Nuvation Bio Inc. |
0 |
0.69% |
|
|
|
|
|
N/A |
0.00% |
1,404.88% |
15.32% |
|---|
| PRTA |
Prothena Corporation plc |
0 |
0.63% |
|
|
|
|
|
N/A |
0.00% |
76.79% |
15.58% |
|---|
| PLRX |
Pliant Therapeutics, Inc. |
0 |
0.61% |
|
|
|
|
|
N/A |
0.00% |
261.05% |
7.64% |
|---|
| ERAS |
Erasca, Inc. |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
261.81% |
28.32% |
|---|
| IRWD |
Ironwood Pharmaceuticals, Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
487.13% |
22.31% |
|---|
| RAPP |
Rapport Therapeutics Inc. |
|
0.53% |
|
|
|
|
|
|
|
|
|
|---|
| IMNM |
Immunome, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
557.08% |
64.77% |
|---|
| DNTH |
Dianthus Therapeutics, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
196.15% |
84.98% |
|---|
| CRGX |
Cargo Therapeutics Inc. |
|
0.50% |
|
|
|
|
|
|
|
|
|
|---|
| KROS |
Keros Therapeutics, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
68.13% |
32.67% |
|---|
| CAPR |
Capricor Therapeutics, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
173.98% |
59.36% |
|---|
| MLYS |
Mineralys Therapeutics, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
88.64% |
5.99% |
|---|
| MBX |
MBX Biosciences Inc. |
|
0.47% |
|
|
|
|
|
|
|
|
|
|---|
| AUTL |
Autolus Therapeutics plc |
0 |
0.46% |
|
|
|
|
|
N/A |
0.00% |
296.60% |
28.05% |
|---|
| STOK |
Stoke Therapeutics, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
579.66% |
15.94% |
|---|
| FLGT |
Fulgent Genetics, Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
49.92% |
27.45% |
|---|
| ANNX |
Annexon, Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
325.54% |
30.07% |
|---|
| SVRA |
Savara Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
296.49% |
75.31% |
|---|
| TRML |
Tourmaline Bio, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
627.22% |
15.52% |
|---|
| ATXS |
Astria Therapeutics, Inc. |
0 |
0.39% |
|
|
|
|
|
N/A |
0.00% |
487.55% |
29.49% |
|---|
| CELC |
Celcuity Inc. |
0 |
0.38% |
|
|
|
|
|
N/A |
0.00% |
69.01% |
12.19% |
|---|
| RNAC |
Cartesian Therapeutics, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
817.74% |
18.13% |
|---|
| TBPH |
Theravance Biopharma, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
557.89% |
11.66% |
|---|
| ARCT |
Arcturus Therapeutics Holdings Inc. |
0 |
0.35% |
|
|
|
|
|
N/A |
0.00% |
118.07% |
56.10% |
|---|
| URGN |
UroGen Pharma Ltd. |
0 |
0.35% |
|
|
|
|
|
N/A |
0.00% |
52.85% |
0.46% |
|---|
| AURA |
Aura Biosciences, Inc. |
0 |
0.32% |
|
|
|
|
|
N/A |
0.00% |
588.45% |
23.15% |
|---|
| ANAB |
AnaptysBio, Inc. |
0 |
0.32% |
|
|
|
|
|
N/A |
0.00% |
90.06% |
27.70% |
|---|
| ZBIO |
ProShares UltraPro Short Nasdaq Biotechn... |
|
0.29% |
|
|
|
|
|
N/A |
0.00% |
1,235.61% |
24.44% |
|---|
| YMAB |
Y-mAbs Therapeutics, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
271.65% |
0.01% |
|---|
| OLMA |
Olema Pharmaceuticals, Inc. |
0 |
0.25% |
|
|
|
|
|
N/A |
0.00% |
225.07% |
20.11% |
|---|
| SLRN |
ACELYRIN Inc. |
|
0.24% |
|
|
|
|
|
|
|
|
|
|---|
| ALDX |
Aldeyra Therapeutics, Inc. |
0 |
0.23% |
|
|
|
|
|
N/A |
0.00% |
239.03% |
19.46% |
|---|
| RIGL |
Rigel Pharmaceuticals, Inc. |
0 |
0.23% |
|
|
|
|
|
N/A |
0.00% |
43.40% |
16.38% |
|---|
| RZLT |
Rezolute, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
156.42% |
23.36% |
|---|
| VNDA |
Vanda Pharmaceuticals Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
538.06% |
23.47% |
|---|
| ITOS |
iTeos Therapeutics Inc. |
|
0.21% |
|
|
|
|
|
|
|
|
|
|---|
| AMLX |
Amylyx Pharmaceuticals, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
65.25% |
32.35% |
|---|
| CMPS |
COMPASS Pathways plc |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
221.64% |
47.21% |
|---|
| LRMR |
Larimar Therapeutics, Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
|---|
| ELDN |
Eledon Pharmaceuticals, Inc. |
0 |
0.19% |
|
|
|
|
|
N/A |
0.00% |
187.04% |
18.22% |
|---|
| FDMT |
4D Molecular Therapeutics, Inc. |
0 |
0.19% |
|
|
|
|
|
N/A |
0.00% |
213.84% |
29.56% |
|---|
|
Cash and Equivalents |
|
0.19% |
|
|
|
|
|
|
|
|
|
|---|
| PROK |
ProKidney Corp. |
0 |
0.18% |
|
|
|
|
|
N/A |
0.00% |
220.22% |
19.33% |
|---|
| ZNTL |
Zentalis Pharmaceuticals, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
298.96% |
23.46% |
|---|
| MGNX |
MacroGenics, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
107.09% |
20.53% |
|---|
| ACRS |
Aclaris Therapeutics, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
|---|
| ALEC |
Alector, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
174.46% |
27.17% |
|---|
| KYTX |
Kyverna Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
476.92% |
54.66% |
|---|
| STRO |
Sutro Biopharma, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
825.03% |
58.52% |
|---|
| ENTA |
Enanta Pharmaceuticals, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
491.20% |
26.96% |
|---|
| 1835589D |
Chinook Therapeutics Inc. |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|